Detection and treatment of ulcerative colitis
AssigneeThe General Hospital Corporation
InventorsDaniel K. Podolsky, Deborah A. Fournier
Life of this patent
Estimating the term…
Abstract
A monoclonal antibody which binds preferentially to colonic glycoproteins of cells of persons having ulcerative colitis, compared to colonic glycoproteins of cells of persons not having ulcerative colitis, and diagnostic and therapeutic uses thereof.
Claims19
A monoclonal antibody produced by a hybridoma selected from the group consisting of ATCC Accession HB 9753 and HB 9756.
A monoclonal antibody which specifically binds to the same epitope as the monoclonal antibody produced by the hybridoma having ATCC Accession No. HB 9753.
A monoclonal antibody which specifically binds to the same epitope as the monoclonal antibody produced by the hybridoma having ATCC Accession No. HB 9756.
The monoclonal antibody produced by the hybridoma given the ATCC Accession No. HB 9753.
The monoclonal antibody produced by the hybridoma given the ATCC Accession No. HB 9756.
A hybridoma which produces a monoclonal antibody which specifically binds to the same epitope as the monoclonal antibody produced by the hybridoma given the ATCC Accession No. HB 9753.
A hybridoma which produces a monoclonal antibody which specifically binds to the same epitope as the monoclonal antibody produced by the hybridoma given the ATCC Accession No. HB 9756.
The hybridoma given the ATCC Accession No. HB 9753.
The hybridoma given the ATCC Accession No. HB 9756.
Dependencies are inferred from the claim text.